ID   PTPRO_HUMAN             Reviewed;        1216 AA.
AC   Q16827; A0AV39; Q13101; Q8IYG3; Q9UBF0; Q9UBT5;
DT   19-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   10-MAY-2017, entry version 164.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase O;
DE            Short=R-PTP-O;
DE            EC=3.1.3.48;
DE   AltName: Full=Glomerular epithelial protein 1;
DE   AltName: Full=Protein tyrosine phosphatase U2;
DE            Short=PTP-U2;
DE            Short=PTPase U2;
DE   Flags: Precursor;
GN   Name=PTPRO; Synonyms=GLEPP1, PTPU2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=7753550;
RA   Seimiya H., Sawabe T., Inazawa J., Tsuruo T.;
RT   "Cloning, expression and chromosomal localization of a novel gene for
RT   protein tyrosine phosphatase (PTP-U2) induced by various
RT   differentiation-inducing agents.";
RL   Oncogene 10:1731-1738(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=7665166; DOI=10.1006/geno.1995.1021;
RA   Wiggins R.C., Wiggins J.E., Goyal M., Wharram B.L., Thomas P.E.;
RT   "Molecular cloning of cDNAs encoding human GLEPP1, a membrane protein
RT   tyrosine phosphatase: characterization of the GLEPP1 protein
RT   distribution in human kidney and assignment of the GLEPP1 gene to
RT   human chromosome 12p12-p13.";
RL   Genomics 27:174-181(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4), AND TISSUE SPECIFICITY.
RX   PubMed=10498613;
RA   Aguiar R.C., Yakushijin Y., Kharbanda S., Tiwari S., Freeman G.J.,
RA   Shipp M.A.;
RT   "PTPROt: an alternatively spliced and developmentally regulated B-
RT   lymphoid phosphatase that promotes G0/G1 arrest.";
RL   Blood 94:2403-2413(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5).
RC   TISSUE=Brain, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INVOLVEMENT IN NPHS6.
RX   PubMed=21722858; DOI=10.1016/j.ajhg.2011.05.026;
RA   Ozaltin F., Ibsirlioglu T., Taskiran E.Z., Baydar D.E., Kaymaz F.,
RA   Buyukcelik M., Kilic B.D., Balat A., Iatropoulos P., Asan E.,
RA   Akarsu N.A., Schaefer F., Yilmaz E., Bakkaloglu A.;
RT   "Disruption of PTPRO causes childhood-onset nephrotic syndrome.";
RL   Am. J. Hum. Genet. 89:139-147(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 916-1208, AND FUNCTION.
RX   PubMed=19167335; DOI=10.1016/j.cell.2008.11.038;
RA   Barr A.J., Ugochukwu E., Lee W.H., King O.N.F., Filippakopoulos P.,
RA   Alfano I., Savitsky P., Burgess-Brown N.A., Mueller S., Knapp S.;
RT   "Large-scale structural analysis of the classical human protein
RT   tyrosine phosphatome.";
RL   Cell 136:352-363(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.19 ANGSTROMS) OF 914-1200.
RX   PubMed=18058037; DOI=10.1007/s10969-007-9036-1;
RA   Almo S.C., Bonanno J.B., Sauder J.M., Emtage S., Dilorenzo T.P.,
RA   Malashkevich V., Wasserman S.R., Swaminathan S., Eswaramoorthy S.,
RA   Agarwal R., Kumaran D., Madegowda M., Ragumani S., Patskovsky Y.,
RA   Alvarado J., Ramagopal U.A., Faber-Barata J., Chance M.R., Sali A.,
RA   Fiser A., Zhang Z.Y., Lawrence D.S., Burley S.K.;
RT   "Structural genomics of protein phosphatases.";
RL   J. Struct. Funct. Genomics 8:121-140(2007).
CC   -!- FUNCTION: Possesses tyrosine phosphatase activity. Plays a role in
CC       regulating the glomerular pressure/filtration rate relationship
CC       through an effect on podocyte structure and function (By
CC       similarity). {ECO:0000250, ECO:0000269|PubMed:19167335}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- SUBUNIT: Interacts (phosphorylated form) with FYN and GRB2.
CC       {ECO:0000250|UniProtKB:E9Q612}.
CC   -!- INTERACTION:
CC       P04626:ERBB2; NbExp=2; IntAct=EBI-723739, EBI-641062;
CC       Q02763:TEK; NbExp=2; IntAct=EBI-723739, EBI-2257090;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q16827-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16827-2; Sequence=VSP_035586;
CC       Name=3; Synonyms=PTPROt;
CC         IsoId=Q16827-3; Sequence=VSP_043136;
CC         Note=Predominantly expressed in B-lymphoid tissues.;
CC       Name=4;
CC         IsoId=Q16827-4; Sequence=VSP_043136, VSP_035586;
CC       Name=5;
CC         IsoId=Q16827-5; Sequence=VSP_054481, VSP_054482;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Glomerulus of kidney. Also detected in brain,
CC       lung and placenta. {ECO:0000269|PubMed:10498613}.
CC   -!- INDUCTION: By various differentiation-inducing agents.
CC   -!- DISEASE: Nephrotic syndrome 6 (NPHS6) [MIM:614196]: A form of
CC       nephrotic syndrome, a renal disease clinically characterized by
CC       severe proteinuria, resulting in complications such as
CC       hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show
CC       non-specific histologic changes such as focal segmental
CC       glomerulosclerosis and diffuse mesangial proliferation. Some
CC       affected individuals have an inherited steroid-resistant form and
CC       progress to end-stage renal failure.
CC       {ECO:0000269|PubMed:21722858}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 3 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z48541; CAA88425.1; -; mRNA.
DR   EMBL; U20489; AAA82892.1; -; mRNA.
DR   EMBL; AF187043; AAF04086.1; -; mRNA.
DR   EMBL; AF187044; AAF04087.1; -; mRNA.
DR   EMBL; AK290982; BAF83671.1; -; mRNA.
DR   EMBL; AC007542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022334; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092183; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471094; EAW96349.1; -; Genomic_DNA.
DR   EMBL; CH471094; EAW96350.1; -; Genomic_DNA.
DR   EMBL; CH471094; EAW96351.1; -; Genomic_DNA.
DR   EMBL; BC035960; AAH35960.1; -; mRNA.
DR   EMBL; BC126201; AAI26202.1; -; mRNA.
DR   EMBL; BC126203; AAI26204.1; -; mRNA.
DR   CCDS; CCDS44837.1; -. [Q16827-3]
DR   CCDS; CCDS53754.1; -. [Q16827-4]
DR   CCDS; CCDS8674.1; -. [Q16827-2]
DR   CCDS; CCDS8675.1; -. [Q16827-1]
DR   PIR; A57064; A57064.
DR   PIR; S60613; S60613.
DR   RefSeq; NP_002839.1; NM_002848.3. [Q16827-2]
DR   RefSeq; NP_109592.1; NM_030667.2. [Q16827-1]
DR   RefSeq; NP_109593.1; NM_030668.2. [Q16827-4]
DR   RefSeq; NP_109594.1; NM_030669.2. [Q16827-3]
DR   RefSeq; NP_109595.1; NM_030670.2. [Q16827-4]
DR   RefSeq; NP_109596.1; NM_030671.2. [Q16827-3]
DR   UniGene; Hs.160871; -.
DR   PDB; 2G59; X-ray; 2.19 A; A/B=914-1200.
DR   PDB; 2GJT; X-ray; 2.15 A; A/B=916-1208.
DR   PDBsum; 2G59; -.
DR   PDBsum; 2GJT; -.
DR   ProteinModelPortal; Q16827; -.
DR   SMR; Q16827; -.
DR   BioGrid; 111764; 11.
DR   IntAct; Q16827; 25.
DR   MINT; MINT-1415956; -.
DR   STRING; 9606.ENSP00000281171; -.
DR   DEPOD; Q16827; -.
DR   iPTMnet; Q16827; -.
DR   PhosphoSitePlus; Q16827; -.
DR   BioMuta; PTPRO; -.
DR   DMDM; 209572663; -.
DR   MaxQB; Q16827; -.
DR   PaxDb; Q16827; -.
DR   PeptideAtlas; Q16827; -.
DR   PRIDE; Q16827; -.
DR   DNASU; 5800; -.
DR   Ensembl; ENST00000281171; ENSP00000281171; ENSG00000151490. [Q16827-1]
DR   Ensembl; ENST00000348962; ENSP00000343434; ENSG00000151490. [Q16827-2]
DR   Ensembl; ENST00000442921; ENSP00000404188; ENSG00000151490. [Q16827-3]
DR   Ensembl; ENST00000445537; ENSP00000393449; ENSG00000151490. [Q16827-3]
DR   Ensembl; ENST00000542557; ENSP00000437571; ENSG00000151490. [Q16827-4]
DR   Ensembl; ENST00000543886; ENSP00000444173; ENSG00000151490. [Q16827-5]
DR   Ensembl; ENST00000544244; ENSP00000439234; ENSG00000151490. [Q16827-4]
DR   GeneID; 5800; -.
DR   KEGG; hsa:5800; -.
DR   UCSC; uc001rcu.3; human. [Q16827-1]
DR   CTD; 5800; -.
DR   DisGeNET; 5800; -.
DR   GeneCards; PTPRO; -.
DR   HGNC; HGNC:9678; PTPRO.
DR   HPA; HPA034525; -.
DR   MalaCards; PTPRO; -.
DR   MIM; 600579; gene.
DR   MIM; 614196; phenotype.
DR   neXtProt; NX_Q16827; -.
DR   OpenTargets; ENSG00000151490; -.
DR   Orphanet; 93214; Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation.
DR   Orphanet; 93217; Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis.
DR   Orphanet; 93213; Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis.
DR   Orphanet; 93216; Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes.
DR   PharmGKB; PA34023; -.
DR   eggNOG; KOG0791; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00870000136384; -.
DR   HOGENOM; HOG000115792; -.
DR   HOVERGEN; HBG053763; -.
DR   InParanoid; Q16827; -.
DR   KO; K18035; -.
DR   OMA; ISSGWPD; -.
DR   OrthoDB; EOG091G00JF; -.
DR   PhylomeDB; Q16827; -.
DR   TreeFam; TF351926; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   ChiTaRS; PTPRO; human.
DR   EvolutionaryTrace; Q16827; -.
DR   GeneWiki; PTPRO; -.
DR   GenomeRNAi; 5800; -.
DR   PRO; PR:Q16827; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000151490; -.
DR   CleanEx; HS_PTPRO; -.
DR   ExpressionAtlas; Q16827; baseline and differential.
DR   Genevisible; Q16827; HS.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; ISS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0030426; C:growth cone; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0016328; C:lateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016791; F:phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; NAS:UniProtKB.
DR   GO; GO:0017147; F:Wnt-protein binding; ISS:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0000902; P:cell morphogenesis; ISS:UniProtKB.
DR   GO; GO:0072112; P:glomerular visceral epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0032835; P:glomerulus development; IMP:UniProtKB.
DR   GO; GO:0030032; P:lamellipodium assembly; ISS:UniProtKB.
DR   GO; GO:0002548; P:monocyte chemotaxis; IMP:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0010812; P:negative regulation of cell-substrate adhesion; ISS:UniProtKB.
DR   GO; GO:0003105; P:negative regulation of glomerular filtration; ISS:UniProtKB.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0090260; P:negative regulation of retinal ganglion cell axon guidance; ISS:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IMP:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0003093; P:regulation of glomerular filtration; ISS:UniProtKB.
DR   GO; GO:0036060; P:slit diaphragm assembly; ISS:UniProtKB.
DR   CDD; cd00063; FN3; 3.
DR   Gene3D; 2.60.40.10; -; 5.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS50853; FN3; 5.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Glycoprotein;
KW   Hydrolase; Membrane; Phosphoprotein; Protein phosphatase; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     29       {ECO:0000255}.
FT   CHAIN        30   1216       Receptor-type tyrosine-protein
FT                                phosphatase O.
FT                                /FTId=PRO_0000025458.
FT   TOPO_DOM     30    822       Extracellular. {ECO:0000255}.
FT   TRANSMEM    823    843       Helical. {ECO:0000255}.
FT   TOPO_DOM    844   1216       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       50    124       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      142    211       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      246    306       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      329    425       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      435    531       Fibronectin type-III 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      532    628       Fibronectin type-III 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      631    724       Fibronectin type-III 7.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      725    817       Fibronectin type-III 8.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      938   1195       Tyrosine-protein phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION     1136   1142       Substrate binding. {ECO:0000250}.
FT   ACT_SITE   1136   1136       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160,
FT                                ECO:0000255|PROSITE-ProRule:PRU10044}.
FT   BINDING    1102   1102       Substrate. {ECO:0000250}.
FT   BINDING    1180   1180       Substrate. {ECO:0000250}.
FT   MOD_RES     865    865       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q612}.
FT   MOD_RES    1210   1210       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:E9Q612}.
FT   CARBOHYD     75     75       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    154    154       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    189    189       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    201    201       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    227    227       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    278    278       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    287    287       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    323    323       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    324    324       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    370    370       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    461    461       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    490    490       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    700    700       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    712    712       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    733    733       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    811       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:10498613,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043136.
FT   VAR_SEQ     594    597       RIAN -> VIFP (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054481.
FT   VAR_SEQ     598   1216       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054482.
FT   VAR_SEQ     876    903       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:10498613,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:7665166}.
FT                                /FTId=VSP_035586.
FT   CONFLICT    159    159       E -> G (in Ref. 1; CAA88425 and 2;
FT                                AAA82892). {ECO:0000305}.
FT   CONFLICT    196    196       S -> C (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    205    205       L -> V (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    314    314       V -> F (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    441    441       V -> F (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    672    672       A -> T (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    698    698       I -> T (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    705    705       A -> T (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    753    753       E -> K (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    756    758       CQQ -> FQH (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    775    775       S -> P (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    790    790       N -> S (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    861    863       VNF -> ANC (in Ref. 1; CAA88425).
FT                                {ECO:0000305}.
FT   CONFLICT    876    876       W -> C (in Ref. 1; CAA88425 and 2;
FT                                AAA82892). {ECO:0000305}.
FT   CONFLICT    896    896       L -> P (in Ref. 1; CAA88425 and 2;
FT                                AAA82892). {ECO:0000305}.
FT   HELIX       920    922       {ECO:0000244|PDB:2GJT}.
FT   HELIX       923    946       {ECO:0000244|PDB:2GJT}.
FT   TURN        947    951       {ECO:0000244|PDB:2GJT}.
FT   HELIX       956    958       {ECO:0000244|PDB:2GJT}.
FT   HELIX       960    965       {ECO:0000244|PDB:2GJT}.
FT   TURN        975    977       {ECO:0000244|PDB:2GJT}.
FT   STRAND      978    980       {ECO:0000244|PDB:2GJT}.
FT   TURN        988    991       {ECO:0000244|PDB:2GJT}.
FT   STRAND      992    998       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1007   1010       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1015   1017       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1018   1027       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1032   1035       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1039   1041       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1053   1056       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1058   1060       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1063   1072       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1074   1085       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1088   1097       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1103   1105       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1108   1127       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1132   1140       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1141   1158       {ECO:0000244|PDB:2GJT}.
FT   STRAND     1160   1162       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1164   1172       {ECO:0000244|PDB:2GJT}.
FT   HELIX      1182   1202       {ECO:0000244|PDB:2GJT}.
SQ   SEQUENCE   1216 AA;  138344 MW;  C902B48D1A73BFE1 CRC64;
     MGHLPTGIHG ARRLLPLLWL FVLFKNATAF HVTVQDDNNI VVSLEASDVI SPASVYVVKI
     TGESKNYFFE FEEFNSTLPP PVIFKASYHG LYYIITLVVV NGNVVTKPSR SITVLTKPLP
     VTSVSIYDYK PSPETGVLFE IHYPEKYNVF TRVNISYWEG KDFRTMLYKD FFKGKTVFNH
     WLPGMCYSNI TFQLVSEATF NKSTLVEYSG VSHEPKQHRT APYPPQNISV RIVNLNKNNW
     EEQSGNFPEE SFMRSQDTIG KEKLFHFTEE TPEIPSGNIS SGWPDFNSSD YETTSQPYWW
     DSASAAPESE DEFVSVLPME YENNSTLSET EKSTSGSFSF FPVQMILTWL PPKPPTAFDG
     FHIHIEREEN FTEYLMVDEE AHEFVAELKE PGKYKLSVTT FSSSGSCETR KSQSAKSLSF
     YISPSGEWIE ELTEKPQHVS VHVLSSTTAL MSWTSSQENY NSTIVSVVSL TCQKQKESQR
     LEKQYCTQVN SSKPIIENLV PGAQYQVVIY LRKGPLIGPP SDPVTFAIVP TGIKDLMLYP
     LGPTAVVLSW TRPYLGVFRK YVVEMFYFNP ATMTSEWTTY YEIAATVSLT ASVRIANLLP
     AWYYNFRVTM VTWGDPELSC CDSSTISFIT APVAPEITSV EYFNSLLYIS WTYGDDTTDL
     SHSRMLHWMV VAEGKKKIKK SVTRNVMTAI LSLPPGDIYN LSVTACTERG SNTSMLRLVK
     LEPAPPKSLF AVNKTQTSVT LLWVEEGVAD FFEVFCQQVG SSQKTKLQEP VAVSSHVVTI
     SSLLPATAYN CSVTSFSHDS PSVPTFIAVS TMVTEMNPNV VVISVLAILS TLLIGLLLVT
     LIILRKKHLQ MARECGAGTF VNFASLERDG KLPYNWRRSI FAFLTLLPSC LWTDYLLAFY
     INPWSKNGLK KRKLTNPVQL DDFDAYIKDM AKDSDYKFSL QFEELKLIGL DIPHFAADLP
     LNRCKNRYTN ILPYDFSRVR LVSMNEEEGA DYINANYIPG YNSPQEYIAT QGPLPETRND
     FWKMVLQQKS QIIVMLTQCN EKRRVKCDHY WPFTEEPIAY GDITVEMISE EEQDDWACRH
     FRINYADEMQ DVMHFNYTAW PDHGVPTANA AESILQFVHM VRQQATKSKG PMIIHCSAGV
     GRTGTFIALD RLLQHIRDHE FVDILGLVSE MRSYRMSMVQ TEEQYIFIHQ CVQLMWMKKK
     QQFCISDVIY ENVSKS
//
